Skip to main content

Advertisement

Table 1 Demographic and clinical profile of the inflammatory bowel disease patients and healthy controls

From: The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China

      UC     CD     IBD Healthy controls P value
    n = 189(%)   n = 37(%)   n = 226(%)   n = 290(%)  
Mean age ± SD (yr) 40.81 ± 15.00 38.78 ± 14.14 40.66 ± 14.90 38.08 ± 14.63 0.888
Male/Female 109/80 23/14 132/94 170/120 0.961
Smoking 45 (23.81%) 9 (24.32%) 54 (23.89%) 101 (34.83%) 0.007*
Drinking 75 (39.68%) 12 (32.43%) 87 (38.50%) 133 (45.86%) 0.093
Diet composition      
 vegetarian food 18 (9.52%) 6 (16.22%) 24 (10.62%) 19 (6.55%) 0.097
 mixed food 171 (90.48%) 31 (83.78%) 202 (89.38%) 271 (93.45%)  
General state      
 fever 32 (16.93%) 4 (10.81%) 36 (15.93%)   
 hemoglobin (g/L) 114.10 ± 23.98 121.22 ± 25.34 115.71 ± 24.37   
 albumin (g/L) 39.97 ± 5.88 38.12 ± 6.44 39.94 ± 6.04   
Disease extent      
 distal colitis 140 (74.07%)     
 pancolitis 49 (25.93%)     
 ileal   8 (21.62%)    
 colonic   14 (37.84%)    
 ileocolonic   15 (44.11%)    
Disease severity      
 mild/moderate 168 30    
 severe 21 (11.1%) 7 (18.92%)    
Treatment      
 ASA/SASP 149 (78.84%) 20 (54.05%) 169 (74.78%)   
 corticosteroids 47 (24.87%) 8 (21.62%) 55 (24.34%)   
 immunodepressant 5 (2.65%) 2 (5.41%) 7 (3.10%)   
  1. CMV, cytomegalovirus; UC, ulcerative colitis; CD, Crohn’s disease; ASA, aminosalicylic acid; SASP, salicylazosulfapyridine.
  2. *indicate significant difference.